Antibiotics save lives, but due to resistant bacteria, we risk losing that ability. Currently the MSB publishes a general overview including a scenario analysis concerning multi-resistant intestinal bacteria. The MSB has the task of analysing risks considered to be especially serious. Within the framework of the National Risk and Capability Assessment, the MSB has compiled a report on multi-resistant intestinal bacteria, including a scenario analysis. The scenario depicts an increased spread of CPE (carbapenemase-producing Enterobacteriaceae, known as ESBLCARBA in Sweden), more specifically in E. coli. The MSB, by way of this report, aims to contribute to this ongoing effort, in hope of increasing awareness of the risks with antibiotic resistance from a civil contingencies’ perspective. This report also goes beyond risk awareness, by including what can be done by actors within civil contingencies to prevent and manage antibiotic resistance in Sweden. Antibiotic resistance is a global issue, and must be addressed as such. We therefore hope that our report will encourage other countries to include the civil contingencies’ perspective in the work on containment of antibiotic resistance. Based on the report, the MSB recommends that: -          concerned parties within emergency preparedness aspire to increase their knowledge of the risks involving antibacterial resistance, especially ESBLCARBA (CPE). -          government agencies with special responsibilities for emergency preparedness, and counties and municipalities, investigate and consider including antibacterial resistance in their respective risk- and vulnerability analyses. -          intentions and measures described in the government agencies’ Action Plan for Containment of Antibiotic Resistance and Healthcare-Associated Infections are executed according to plan. -          responsible actors enable and develop Swedish government agencies’ international work on containment of antibiotic resistance.